Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.